| Pharmacological interventions for promoting smoking cessation during pregnancy R Claire, C Chamberlain, MA Davey, SE Cooper, I Berlin, J Leonardi‐Bee, ... Cochrane database of systematic reviews, 2020 | 590 | 2020 |
| Using Trial Sequential Analysis for estimating the sample sizes of further trials: example using smoking cessation intervention R Claire, C Gluud, I Berlin, T Coleman, J Leonardi-Bee BMC Medical Research Methodology 20, 1-10, 2020 | 40 | 2020 |
| Fetal safety of nicotine replacement therapy in pregnancy: systematic review and meta‐analysis L Taylor, R Claire, K Campbell, T Coleman‐Haynes, J Leonardi‐Bee, ... Addiction 116 (2), 239-277, 2021 | 35 | 2021 |
| Comparison of nicotine exposure during pregnancy when smoking and abstinent with nicotine replacement therapy: systematic review and meta‐analysis C Hickson, S Lewis, KA Campbell, S Cooper, I Berlin, R Claire, C Oncken, ... Addiction 114 (3), 406-424, 2019 | 27 | 2019 |
| Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches R Claire, T Coleman, J Leonardi‐Bee, I Berlin Addiction 114 (9), 1651-1658, 2019 | 8 | 2019 |
| Comparison of saliva cotinine and exhaled carbon monoxide concentrations when smoking and after being offered dual nicotine replacement therapy in pregnancy B Slaich, R Claire, J Emery, S Lewis, S Cooper, R Thomson, L Phillips, ... Addiction 117 (3), 751-759, 2022 | 5 | 2022 |
| Prognostic factors of COVID‐19: an umbrella review endorsed by the International Society for Pharmacoepidemiology G Sarri, W Liu, L Zabotka, A Freitag, R Claire, G Wangge, J Elvidge, ... Clinical Pharmacology & Therapeutics 114 (3), 604-613, 2023 | 2 | 2023 |
| Systematic review and meta‐analysis investigating nicotine, cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy A Podlasek, R Claire, KA Campbell, S Orton, R Thomson, T Coleman Addiction 118 (11), 2076-2092, 2023 | 1 | 2023 |
| RWD147 demonstrating the application of real-world evidence for health technology assessment using a federated data network R Claire, J Elvidge, C Read, T Debray, D Newby, E Burn, D Dawoud Value in Health 25 (12), S478, 2022 | 1 | 2022 |
| Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop R Claire, J Elvidge, S Hanif, H Goovaerts, PR Rijnbeek, P Jónsson, ... Frontiers in Pharmacology 14, 1289365, 2024 | | 2024 |
| RWD49 Real-World Evidence From a Federated Data Network to Reduce Uncertainty in the Long-Term Extrapolations of Oncology Treatments J Dietz, R Claire, J Love-Koh, J Elvidge, D Newby, E Burn, D Dawoud Value in Health 26 (12), S513, 2023 | | 2023 |
| RWD24 Decision Making and the Questions Raised When Real World Evidence From a Federated Data Network Conflicts With RCT Data: A Use Case on COVID-19 Treatments C Read, R Claire, J Elvidge, J Dietz, T Debray, MA Mayer, JMR Anguita, ... Value in Health 26 (12), S508, 2023 | | 2023 |
| Real-world continuous glucose monitoring in adults with type 1 and type 2 diabetes G Sarri, L Zabotka, A Freitag, R Claire, G Wangge PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 432-433, 2022 | | 2022 |
| Did publication urgency during the pandemic trade-off for epidemiological rigorousness? Results from an umbrella review G Sarri, L Zabotka, A Freitag, R Claire, G Wangge International Conference of Pharmacoepidemiology 2022: Advancing …, 2022 | | 2022 |
| Assessing the efficacy of Nicotine Replacement Therapy for smoking cessation during pregnancy R Claire University of Nottingham, 2021 | | 2021 |
| D6. 2 Report on Global Regulatory Best Practices Analysis: A scoping review of HTA and Regulatory RWD/RWE policy documents R Claire, K Cresswell, TS Avsar, D Dawoud, H Colvin, K Chen, ... | | |
| Medikamentöse Behandlungen und elektronische Zigaretten zur Raucherentwöhnung in der Schwangerschaft R Claire, C Chamberlain, MA Davey, SE Cooper, I Berlin, J Leonardi-Bee, ... | | |
